HLA-A and neoplasm: Corroborating this result, five out of six untreated patient samples turned out to contain memory CD8+ T cells responsive to the spliced HLA-A*03:01-restricted epitope gp100mel195–202/191 [RSYVPLAH][R] that had initially been identified through the analysis of tumor infiltrating lymphocytes18.